Iridex (IRIX) EBITDA Margin Growth (3y) (2013 - 2026)
Iridex (IRIX) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -201.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 586.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 736.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 887.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 963.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 212.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 535.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 244.00 |
| 10 | Iridex | 13.27 Mn | 8.59 Mn | 4.30 Mn | 1,432.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1,436.00 |
| Jan 3, 2026 | 918.00 |
| Sep 27, 2025 | 28.00 |
| Jun 28, 2025 | 878.00 |
| Mar 29, 2025 | 1,529.00 |
| Dec 28, 2024 | 23.00 |
| Sep 28, 2024 | 11.00 |
| Jun 29, 2024 | -1,241.00 |
| Mar 30, 2024 | -1,261.00 |
| Sep 30, 2023 | 783.00 |
| Jul 1, 2023 | 2,225.00 |
| Apr 1, 2023 | 122.00 |
| Dec 31, 2022 | 447.00 |
| Oct 1, 2022 | 579.00 |
| Jul 2, 2022 | 797.00 |
| Apr 2, 2022 | 1,165.00 |
| Jan 1, 2022 | 2,118.00 |
| Oct 2, 2021 | 1,077.00 |
| Jul 3, 2021 | 2,338.00 |
| Apr 3, 2021 | 2,264.00 |